PPARG and type 2 diabetes mellitus: The thiazolidinediones (TZDs) or glitazones (e.g., rosiglitazone and pioglitazone) are considered as specific ligands for PPARγ and are being used for treating hyperglycemia in patients with type 2 diabetes.